Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection
Marc K. Hellerstein, … , Richard A. Neese, Joseph M. McCune
Marc K. Hellerstein, … , Richard A. Neese, Joseph M. McCune
Published September 15, 2003
Citation Information: J Clin Invest. 2003;112(6):956-966. https://doi.org/10.1172/JCI17533.
View: Text | PDF
Article Virology Article has an altmetric score of 4

Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection

  • Text
  • PDF
Abstract

Antigenic stimulation of T cells gives rise to short-lived effector cells and long-lived memory cells. We used two stable isotope-labeling techniques to identify kinetically distinct subpopulations of T cells and to determine the effect of advanced infection with HIV-1. Long-term deuterated water (2H2O) incorporation into DNA demonstrated biphasic accrual of total and of memory/effector (m/e)–phenotype but not naive-phenotype T cells, consistent with the presence of short-lived and longer-lived subpopulations within the m/e-phenotype T cell pool. These results were mirrored by biphasic die-away kinetics in m/e- but not naive-phenotype T cells after short-term 2H-glucose labeling. Persistent label retention was observed in a subset of m/e-phenotype T cells (presumably memory T cells), confirming the presence of T cells with very different life spans in humans. In advanced HIV-1 infection, much higher proportions of T cells were short-lived, compared to healthy controls. Effective long-term anti-retroviral therapy restored values to normal. These results provide the first quantitative evidence that long-lived and quiescent T cells do indeed predominate in the T cell pool in humans and determine T cell pool size, as in rodents. The greatest impact of advanced HIV-1 infection is to reduce the generation of long-lived, potential progenitor T cells.

Authors

Marc K. Hellerstein, Rebecca A. Hoh, Mary Beth Hanley, Denise Cesar, Daniel Lee, Richard A. Neese, Joseph M. McCune

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Time course of long-term oral 2H2O label incorporation into CD4+ and CD8...
Time course of long-term oral 2H2O label incorporation into CD4+ and CD8+ T cell DNA in different groups. (a) Time course of fractional synthesis of T cell DNA in different clinical groups. f, fractional synthesis or percent newly divided cells present, as described in Results. (b) 2H2O enrichment in body water. 2H2O was given as an initial loading dose on day 0 then given daily for 9 weeks by mouth. Urine and saliva were collected weekly and 2H2O enrichment was measured by GC/MS (10, 22). (c) 2H-enrichment in blood monocytes/granulocytes (average for group as a whole). (d) Summary of phase I and phase II T cell proliferation during long-term 2H2O incorporation in the three groups: healthy controls, untreated HIV-1/AIDS, and LT ARV therapy. *P < 0.05 vs. normal controls; **P < 0.05 vs. HIV-1/AIDS. Number of subjects shown above bars. Data shown are mean ± SD.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 Wikipedia pages
Highlighted by 1 platforms
30 readers on Mendeley
See more details